HCA Healthcare reported a revenue increase to $16.213 billion, up from $14.971 billion in Q3 2022. Net income attributable to HCA Healthcare, Inc. was $1.079 billion, or $3.91 per diluted share, which is slightly lower than the $1.134 billion reported in Q3 2022. The company revised its 2023 guidance for revenue, net income, and adjusted EBITDA.
Revenues totaled $16.213 billion, marking an increase from the previous year.
Net income attributable to HCA Healthcare, Inc. reached $1.079 billion, or $3.91 per diluted share.
Adjusted EBITDA amounted to $2.880 billion.
Same facility admissions increased by 3.4 percent, and same facility equivalent admissions rose by 4.1 percent.
HCA Healthcare revised its 2023 guidance, with revenue expected to be between $63.5 billion and $64.5 billion, net income attributable to HCA Healthcare, Inc. between $4.940 billion and $5.130 billion, and adjusted EBITDA between $12.3 billion and $12.6 billion.